Disease details

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02084121 (ClinicalTrials.gov)	March 2014	7/3/2014	Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)	Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)	Metachromatic Leukodystrophy	Biological: Enriched Hematopoetic Stem Cell Infusion	Talaris Therapeutics Inc.	Duke University	No longer available	3 Years	N/A	Male			United States
2	NCT00497952 (ClinicalTrials.gov)	July 2007	6/7/2007	Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis	Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis	Multiple Sclerosis	Biological: hematopoetic stem cell infusion	Talaris Therapeutics Inc.	NULL	Active, not recruiting	18 Years	55 Years	All	3	Phase 1/Phase 2	United States